FCFC is a listed company. Filings by its managers are published through TWSE / TPEx (MOPS). 1 insider has disclosed 2 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Insider buying of FCFC has been absent for the past year.
For context, the typical company on the same exchange (median of 515 companies) published 2 filings over the same period, against 2 filings here.
Every figure here comes from the filings published by TWSE / TPEx (MOPS) and describes the past, not future prices; it is not investment advice.
Analysts rate FCFC Buy (bullish), based on 6 analysts. Average price target: NT$66.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
台化 is a company listed on the XTAI market, specializing in the production of chemicals and materials. It plays a key role in the chemical industry in Taiwan.